Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/naloxone prolonged-release versus oxycodone prolonged-release for opioid-induced constipation in adults with cancer or non-cancer pain
2009-012051-20Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone + naloxone and oxycodone in cancer pain and chronic pain (2 arms), sponsored by Mundipharma. Primary endpoint: Change in intensity of constipation symptoms. Started Jul 2009; status: completed.
02
Drugs
oxycodone + naloxoneoxycodone
03
Conditions
cancer painchronic pain
Beyond the preview
Go deeper on 2009-012051-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012051-20.